Sign in or Register   Sign in or Register
  |  

Armenian Hamster Anti-NOTCH4 Recombinant Antibody (HMN4-14) (CBMAB-1074-LY)

This product is armenian hamster antibody recognizes mouse NOTCH4. The antibody HMN4-14 immunoassay techniques such as: Neutralization.
See all NOTCH4 antibodies

Summary

Host Animal
Armenian Hamster
Specificity
Mouse
Clone
HMN4-14
Antibody Isotype
IgG
Application
Neutralization

Basic Information

Specificity
Mouse
Antibody Isotype
IgG
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
Notch 4
Introduction
Functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs.
Entrez Gene ID
18132
UniProt ID
P31695
Alternative Names
N4; Int3; Int-3
Function
Functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs. May regulate branching morphogenesis in the developing vascular system (By similarity).
Biological Process
Branching involved in blood vessel morphogenesisISS:UniProtKB
Cell differentiation1 PublicationNAS:UniProtKB
Cell fate determinationManual Assertion Based On ExperimentTAS:UniProtKB
Endothelial cell morphogenesisIEA:Ensembl
Epithelial to mesenchymal transitionManual Assertion Based On ExperimentIMP:ARUK-UCL
HemopoiesisManual Assertion Based On ExperimentTAS:UniProtKB
Mammary gland developmentManual Assertion Based On ExperimentIDA:UniProtKB
Morphogenesis of a branching structureISS:UniProtKB
Negative regulation of cell adhesion molecule productionManual Assertion Based On ExperimentIMP:ARUK-UCL
Negative regulation of cell differentiation1 PublicationNAS:UniProtKB
Negative regulation of cell-cell adhesion mediated by cadherinManual Assertion Based On ExperimentIMP:ARUK-UCL
Negative regulation of endothelial cell differentiationISS:UniProtKB
Negative regulation of transcription by RNA polymerase IIManual Assertion Based On ExperimentIMP:ARUK-UCL
Positive regulation of transcription of Notch receptor targetManual Assertion Based On ExperimentTAS:BHF-UCL
Positive regulation of transcription, DNA-templatedManual Assertion Based On ExperimentTAS:UniProtKB
Vasculature developmentISS:UniProtKB
Wound healingIEA:Ensembl
Cellular Location
Cell membrane
Notch 4 intracellular domain
Nucleus
Following proteolytical processing NICD is translocated to the nucleus.
Topology
Extracellular: 24-1447
Helical: 1448-1468
Cytoplasmic: 1469-2003
PTM
Synthesized in the endoplasmic reticulum as an inactive form which is proteolytically cleaved by a furin-like convertase in the trans-Golgi network before it reaches the plasma membrane to yield an active, ligand-accessible form. Cleavage results in a C-terminal fragment N(TM) and a N-terminal fragment N(EC). Following ligand binding, it is cleaved by TNF-alpha converting enzyme (TACE) to yield a membrane-associated intermediate fragment called notch extracellular truncation (NEXT). This fragment is then cleaved by presenilin dependent gamma-secretase to release a notch-derived peptide containing the intracellular domain (NICD) from the membrane (By similarity).
Phosphorylated.

Guo, M., Zhang, M., Cao, X., Fang, X., Li, K., Qin, L., ... & Li, X. (2022). Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension. Respiratory Research, 23(1), 1-18.

Muley, A., Kim Uh, M., Salazar-De Simone, G., Swaminathan, B., James, J. M., Murtomaki, A., ... & Shawber, C. J. (2022). Unique functions for Notch4 in murine embryonic lymphangiogenesis. Angiogenesis, 1-20.

Scheurlen, K. M., Chariker, J. H., Kanaan, Z., Littlefield, A. B., George, J. B., Seraphine, C., ... & Galandiuk, S. (2022). The NOTCH4-GATA4-IRG1 axis as a novel target in early-onset colorectal cancer. Cytokine & Growth Factor Reviews.

Xiu, M., Zeng, X., Shan, R., Wen, W., Li, J., & Wan, R. (2021). Targeting Notch4 in cancer: molecular mechanisms and therapeutic perspectives. Cancer Management and Research, 7033-7045.

Long, J., Wang, D., Yang, X., Wang, A., Lin, Y., Zheng, M., ... & Zhao, H. (2021). Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy. BMC medicine, 19(1), 1-14.

Harb, H., Benamar, M., Lai, P. S., Contini, P., Griffith, J. W., Crestani, E., ... & Chatila, T. A. (2021). Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections. Immunity, 54(6), 1186-1199.

López-López, S., Romero de Ávila, M. J., Hernández de León, N. C., Ruiz-Marcos, F., Baladrón, V., Nueda, M. L., ... & Díaz-Guerra, M. J. M. (2021). NOTCH4 exhibits anti-inflammatory activity in activated macrophages by interfering with interferon-γ and TLR4 signaling. Frontiers in Immunology, 12, 734966.

Harb, H., Stephen-Victor, E., Crestani, E., Benamar, M., Massoud, A., Cui, Y., ... & Chatila, T. A. (2020). A regulatory T cell Notch4–GDF15 axis licenses tissue inflammation in asthma. Nature immunology, 21(11), 1359-1370.

Zhou, L., Wang, D., Sheng, D., Xu, J., Chen, W., Qin, Y., ... & Zhang, L. (2020). NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer. Theranostics, 10(5), 2405.

Lv, H., Nan, Z., Jiang, P., Wang, Z., Song, M., Ding, H., ... & Hu, Y. (2019). Vascular endothelial growth factor 165 inhibits pro-fibrotic differentiation of stromal cells via the DLL4/Notch4/smad7 pathway. Cell Death & Disease, 10(9), 681.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Armenian Hamster Anti-NOTCH4 Recombinant Antibody (HMN4-14)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare